Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
11m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
44m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
44m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
44m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
44m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Nurix Therapeutics Inc logo

Nurix Therapeutics Inc

About

Nurix Therapeutics Inc (NASDAQ:NRIX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
Apr 8 2026
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Apr 7 2026
Nurix Therapeutics to Participate in Upcoming Investor Conference
Mar 23 2026
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
Jan 28 2026
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update

Financials

Revenue
$83.98 M
Market Cap
$1.63 B
EPS
-3.05

Community Chat

Ask AI

6ix6ixAIEvents